Literature DB >> 25124870

Hyaluronan in aged collagen matrix increases prostate epithelial cell proliferation.

Mamatha Damodarasamy1, Robert B Vernon, Christina K Chan, Stephen R Plymate, Thomas N Wight, May J Reed.   

Abstract

The extracellular matrix (ECM) of the prostate, which is comprised primarily of collagen, becomes increasingly disorganized with age, a property that may influence the development of hyperplasia and cancer. Collageous ECM extracted from the tails of aged mice exhibits many characteristics of collagen in aged tissues, including the prostate. When polymerized into a 3-dimensional (3D) gel, these collagen extracts can serve as models for the study of specific cell-ECM interactions. In the present study, we examined the behaviors of human prostatic epithelial cell lines representing normal prostate epithelial cells (PEC), benign prostatic hyperplasia (BPH-1), and adenocarcinoma (LNCaP) cultured in contact with 3D gels made from collagen extracts of young and aged mice. We found that proliferation of PEC, BPH-1, and LNCaP cells were all increased by culture on aged collagen gels relative to young collagen gels. In examining age-associated differences in the composition of the collagen extracts, we found that aged and young collagen had a similar amount of several collagen-associated ECM components, but aged collagen had a much greater content of the glycosaminoglycan hyaluronan (HA) than young collagen. The addition of HA (of similar size and concentration to that found in aged collagen extracts) to cells placed in young collagen elicited significantly increased proliferation in BPH-1 cells, but not in PEC or LNCaP cells, relative to controls not exposed to HA. Of note, histochemical analyses of human prostatic tissues showed significantly higher expression of HA in BPH and prostate cancer stroma relative to stroma of normal prostate. Collectively, these results suggest that changes in ECM involving increased levels of HA contribute to the growth of prostatic epithelium with aging.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25124870      PMCID: PMC4571456          DOI: 10.1007/s11626-014-9800-z

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  52 in total

1.  Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.

Authors:  V B Lokeshwar; D Rubinowicz; G L Schroeder; E Forgacs; J D Minna; N L Block; M Nadji; B L Lokeshwar
Journal:  J Biol Chem       Date:  2001-01-19       Impact factor: 5.157

Review 2.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

3.  Hyaluronan enhances wound repair and increases collagen III in aged dermal wounds.

Authors:  Mamatha Damodarasamy; Richard S Johnson; Itay Bentov; Michael J MacCoss; Robert B Vernon; May J Reed
Journal:  Wound Repair Regen       Date:  2014 Jul-Aug       Impact factor: 3.617

4.  Taking cell-matrix adhesions to the third dimension.

Authors:  E Cukierman; R Pankov; D R Stevens; K M Yamada
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

5.  Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distribution.

Authors:  A Goulas; D G Hatzichristou; G Karakiulakis; V Mirtsou-Fidani; A Kalinderis; E Papakonstantinou
Journal:  Prostate       Date:  2000-07-01       Impact factor: 4.104

6.  Stimulation of Hyaluronan synthetase by platelet-derived growth factor bb in human prostate smooth muscle cells.

Authors:  M Pullen; K Thomas; H Wu; P Nambi
Journal:  Pharmacology       Date:  2001-02       Impact factor: 2.547

Review 7.  Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.

Authors:  Mohamed Saad; Mona Abdel-Rahim; Hassan Abol-Enein; Mohammed A Ghoneim
Journal:  BJU Int       Date:  2008-06-19       Impact factor: 5.588

8.  Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts.

Authors:  Thomas S Wilkinson; Susan Potter-Perigo; Christina Tsoi; Leonard C Altman; Thomas N Wight
Journal:  Am J Respir Cell Mol Biol       Date:  2004-02-05       Impact factor: 6.914

9.  Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression.

Authors:  Eman Sadoun; May J Reed
Journal:  J Histochem Cytochem       Date:  2003-09       Impact factor: 2.479

10.  Collagen density promotes mammary tumor initiation and progression.

Authors:  Paolo P Provenzano; David R Inman; Kevin W Eliceiri; Justin G Knittel; Long Yan; Curtis T Rueden; John G White; Patricia J Keely
Journal:  BMC Med       Date:  2008-04-28       Impact factor: 8.775

View more
  5 in total

1.  Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population.

Authors:  Su Kang Kim; Hyun Kyung Park; Han Sung Choi; Koo Han Yoo; Joo-Ho Chung
Journal:  Int Neurourol J       Date:  2016-12-26       Impact factor: 2.835

Review 2.  Collagen and Discoidin Domain Receptor 1 Partnership: A Multifaceted Role in the Regulation of Breast Carcinoma Cell Phenotype.

Authors:  Charles Saby; Erik Maquoi; Frédéric Saltel; Hamid Morjani
Journal:  Front Cell Dev Biol       Date:  2021-12-22

3.  Decreased Laminin Expression by Human Lung Epithelial Cells and Fibroblasts Cultured in Acellular Lung Scaffolds from Aged Mice.

Authors:  Lindsay M Godin; Brian J Sandri; Darcy E Wagner; Carolyn M Meyer; Andrew P Price; Ifeolu Akinnola; Daniel J Weiss; Angela Panoskaltsis-Mortari
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

4.  Type I collagen aging impairs discoidin domain receptor 2-mediated tumor cell growth suppression.

Authors:  Charles Saby; Emilie Buache; Sylvie Brassart-Pasco; Hassan El Btaouri; Marie-Pierre Courageot; Laurence Van Gulick; Roselyne Garnotel; Pierre Jeannesson; Hamid Morjani
Journal:  Oncotarget       Date:  2016-05-03

5.  Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling.

Authors:  Yu Dong; Jiakuan Liu; Zesheng Xue; Jingya Sun; Zhengnan Huang; Yifeng Jing; Bangmin Han; Bing Shen; Jun Yan; Ruimin Huang
Journal:  BMC Complement Med Ther       Date:  2020-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.